Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email